Eric J. Nestler, MD, PhD, to Lead Society for Neuroscience
Eric J. Nestler, MD, PhD, Nash Family Professor and Chair of the Department of Neuroscience and Director of the Friedman Brain Institute (FBI) at the Icahn School of Medicine at Mount Sinai, has been named president-elect of the Society for Neuroscience, the world’s largest organization of brain and nervous system scientists and physicians, effective at the 2015 annual meeting to be held this fall in Chicago. The nonprofit organization, founded in 1969, now has nearly 40,000 members in more than 90 countries around the world.
Dr. Nestler’s research focuses on the neurobiological basis of drug addiction and depression. His laboratory, which is funded by the National Institute on Drug Abuse, National Institute of Mental Health and the Hope for Depression Research Foundation, has pioneered studies to understand, at the molecular level, how drugs of abuse and stress change nerve cells and their brain circuits to cause behavioral abnormalities and to use this knowledge to develop improved treatments.
“Since Dr. Nestler assumed his current position at Mount Sinai in 2008, he has overseen transformational growth of the neuroscience community under the auspices of The Friedman Brain Institute,” says Kenneth L. Davis, MD, president and chief executive officer of the Mount Sinai Health System. “We are so pleased that the Society for Neuroscience has recognized his leadership excellence. I have no doubt that his vision for and commitment to a better understanding of the nervous system will benefit the SFN, as it has for the neurosciences here at Mount Sinai.”
Uniquely, the Friedman Brain Institute integrates all neuroscience efforts throughout Mount Sinai, from basic research in animal and cell models in the Icahn School of Medicine to the delivery of clinical care across the Mount Sinai Health System. Under Dr. Nestler’s leadership, the neuroscience program has seen an unprecedented scope of growth. In the past seven years, more than 30 basic neuroscience faculty have been recruited to Mount Sinai, with clinical research and treatment programs experiencing similar expansion. The FBI’s research and clinical faculty members are national and international leaders, committed to an improved understanding of the nervous system and to real clinical advances in diagnosis and treatment across a broad range of brain and spinal cord disorders. The Fishberg Department of Neuroscience at Mount Sinai is ranked #3 in the nation for funding from the National Institutes of Health.
Dr. Nestler will assume the presidency at the 2016 annual meeting.
To learn more about the Friedman Brain Institute, please visit: www.mountsinai.org/fbi
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.